A program to support patients with diabetes and kidney diseases through SMS communication.
Official title: NIDDK / HALO LINK 1-YEAR SMS POP: 9/1/2024 THRU 8/31/2025
NIH-11215088 · Data updated 2026-11-12
This study is testing a year-long text message program to help people with diabetes and kidney diseases stay engaged and supported in managing their health by sending them helpful tips, reminders, and encouragement right to their phones.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project start | September 1, 2024 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $18,711 |
| NIH project number | 75N94024F00081-0-0-1 |
| Project ID | NIH-11215088 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this program are individuals diagnosed with diabetes or kidney diseases who are open to receiving health-related text messages.
✕Less likely to help
Patients who do not have access to mobile phones or prefer not to use SMS communication may not benefit from this research.
What this research studies
This research focuses on enhancing patient engagement and support for individuals with diabetes and kidney diseases through a one-year SMS communication program. Patients will receive regular text messages that provide information, reminders, and encouragement related to their health management. The approach aims to improve adherence to treatment plans and promote healthier lifestyle choices. By utilizing SMS technology, the program seeks to reach patients in a convenient and accessible manner.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and better management of diabetes and kidney diseases for patients.
How similar studies have gone: Previous research has shown that SMS-based interventions can effectively improve health outcomes in patients with chronic conditions, indicating a promising approach.
Where this research is happening
Fairfax, United States
Researchers
- Principal investigator: Robinson, Mindy
- Study coordinator: Robinson, Mindy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.